GR61241B - 2,6-dimethyl-3-methoxycarbonyl-4-(2-nitrophenyl)-1,4-dihydropyridin-5-isobutylester of carbonic acid preparation process thereof and use thereof as coronartherapeutical - Google Patents

2,6-dimethyl-3-methoxycarbonyl-4-(2-nitrophenyl)-1,4-dihydropyridin-5-isobutylester of carbonic acid preparation process thereof and use thereof as coronartherapeutical

Info

Publication number
GR61241B
GR61241B GR52093A GR760152093A GR61241B GR 61241 B GR61241 B GR 61241B GR 52093 A GR52093 A GR 52093A GR 760152093 A GR760152093 A GR 760152093A GR 61241 B GR61241 B GR 61241B
Authority
GR
Greece
Prior art keywords
coronartherapeutical
isobutylester
dihydropyridin
methoxycarbonyl
nitrophenyl
Prior art date
Application number
GR52093A
Other languages
Greek (el)
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of GR61241B publication Critical patent/GR61241B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR52093A 1975-11-05 1976-11-04 2,6-dimethyl-3-methoxycarbonyl-4-(2-nitrophenyl)-1,4-dihydropyridin-5-isobutylester of carbonic acid preparation process thereof and use thereof as coronartherapeutical GR61241B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2549568A DE2549568C3 (de) 1975-11-05 1975-11-05 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
GR61241B true GR61241B (en) 1978-10-12

Family

ID=5960951

Family Applications (1)

Application Number Title Priority Date Filing Date
GR52093A GR61241B (en) 1975-11-05 1976-11-04 2,6-dimethyl-3-methoxycarbonyl-4-(2-nitrophenyl)-1,4-dihydropyridin-5-isobutylester of carbonic acid preparation process thereof and use thereof as coronartherapeutical

Country Status (27)

Country Link
JP (1) JPS5259161A (pt)
AT (1) AT352129B (pt)
AU (1) AU498964B2 (pt)
BE (1) BE847968A (pt)
BG (6) BG24804A3 (pt)
CA (1) CA1085406A (pt)
CH (2) CH623038A5 (pt)
CS (1) CS200499B2 (pt)
DE (1) DE2549568C3 (pt)
DK (1) DK146762C (pt)
ES (2) ES452986A1 (pt)
FI (1) FI60704C (pt)
FR (1) FR2330395A1 (pt)
GB (1) GB1516793A (pt)
GR (1) GR61241B (pt)
HK (1) HK12681A (pt)
IE (1) IE43984B1 (pt)
IL (1) IL50817A (pt)
LU (2) LU76133A1 (pt)
NL (2) NL175915C (pt)
NO (1) NO145574C (pt)
NZ (1) NZ182502A (pt)
PL (2) PL106084B1 (pt)
PT (1) PT65797B (pt)
RO (1) RO70295A (pt)
SE (1) SE423542B (pt)
ZA (1) ZA766622B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE3212736A1 (de) * 1982-04-06 1983-10-13 Bayer Ag, 5090 Leverkusen Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS5982192U (ja) * 1982-11-27 1984-06-02 エムケ−精工株式会社
DE3312216A1 (de) * 1983-04-05 1984-10-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von symmetrischen 1,4-dihydropyridincarbonsaeureestern
DE3312283A1 (de) * 1983-04-05 1984-10-18 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von unsymmetrischen 1,4-dihydropyridincarbonsaeureestern
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
DE2549568A1 (de) 1977-05-18
IL50817A (en) 1979-07-25
DK146762C (da) 1984-06-12
JPS5259161A (en) 1977-05-16
GB1516793A (en) 1978-07-05
NO145574C (no) 1982-04-21
DK498476A (da) 1977-05-06
NL7612198A (nl) 1977-05-09
CH623038A5 (en) 1981-05-15
BG25078A3 (en) 1978-07-12
NL930035I2 (nl) 1993-10-01
NZ182502A (en) 1978-07-28
DE2549568B2 (de) 1980-08-21
BG25079A3 (en) 1978-07-12
FI60704C (fi) 1982-03-10
NL930035I1 (nl) 1993-08-02
IL50817A0 (en) 1977-01-31
NO763608L (pt) 1977-05-06
BG24668A3 (en) 1978-04-12
FR2330395A1 (fr) 1977-06-03
FI60704B (fi) 1981-11-30
ES463166A1 (es) 1978-07-16
PT65797B (de) 1978-05-12
FR2330395B1 (pt) 1978-12-22
CH622779A5 (en) 1981-04-30
PL106084B1 (pl) 1979-11-30
BG24804A3 (en) 1978-05-12
CA1085406A (en) 1980-09-09
PL105940B1 (pl) 1979-11-30
BE847968A (fr) 1977-05-04
CS200499B2 (en) 1980-09-15
AU1935876A (en) 1978-05-11
ATA814276A (de) 1979-02-15
DK146762B (da) 1983-12-27
BG24803A3 (en) 1978-05-12
LU88275I2 (pt) 1994-02-03
AU498964B2 (en) 1979-03-29
FI763160A (pt) 1977-05-06
LU76133A1 (pt) 1977-06-02
NO145574B (no) 1982-01-11
RO70295A (ro) 1981-08-17
NL175915C (nl) 1985-01-16
JPS5647185B2 (pt) 1981-11-07
IE43984L (en) 1977-05-05
SE7612308L (sv) 1977-05-06
DE2549568C3 (de) 1981-10-29
ES452986A1 (es) 1977-12-16
AT352129B (de) 1979-09-10
IE43984B1 (en) 1981-07-15
PT65797A (de) 1976-12-01
ZA766622B (en) 1977-10-26
HK12681A (en) 1981-04-10
SE423542B (sv) 1982-05-10
BG24805A3 (en) 1978-05-12

Similar Documents

Publication Publication Date Title
GR60789B (en) Preparation process of 2,4-dichlor-4'-benzoylureido-diphenylether and use thereof as insecticides
GR61175B (en) Preparation process of (1-phenyl-2-triazolyl-ethyl)-ether-derivatives and use thereof as fungicides
ATA388376A (de) Verfahren zur herstellung einer neuen kristallinen form von flunisolid
GR60835B (en) Preparation process of delta15-steroids
GR59482B (en) Preparation process of novel biphenyloxy-derivatives
GR60435B (en) Preparation process of acylamino-derivatives
GR60047B (en) Preparation process of 11-desoxy-16-aryloxy-omega-tetranorprostaglandins
GR61241B (en) 2,6-dimethyl-3-methoxycarbonyl-4-(2-nitrophenyl)-1,4-dihydropyridin-5-isobutylester of carbonic acid preparation process thereof and use thereof as coronartherapeutical
GR63123B (en) Preparation process of novel 1,4-diphenyl-3-pyrazolin-5-ones
JPS5247822A (en) Perylenee3*4*9*100tetracarboxylic acid diimide pigments* process for manufacture thereof and use thereof
JPS5233649A (en) Compositions of substances and process
GR60849B (en) Preparation process of l-pyroglutamyl-l-prolinamide
GR60822B (en) Preparation process of novel homophthalimides
GR61290B (en) Compositions fighting parasites and preparation process thereof
JPS5231047A (en) Production of novel 2*33 dihalogennalkanoyllurea and use of same as pesticide
GB1554310A (en) Process for the preparation of 5-oxo-hexanoic acid and derivatives thereof
GR61598B (en) Disubstituted phenolethers of 3-amino-2-hydroxypropan,preparation process thereof and use thereof as medicines
JPS5217454A (en) Preparation and use of novel 22hydroxynaphthalinee 11aldehyde
GR61185B (en) Preparation process of 6b 17-dihydroxy-7a-(lower alkoxy)carbonyl-3-oxo-17a-pregn-4-ene-21-carboxylic acid gamma-lactones and congeners
PH12132A (en) Anti-allergic n-(5-tetrazolyl)-1-oxo-1h-6-alkoxypyrimido(1,2-a)-quinoline-2-carboxamides,compositions containing them,and their methods of use
JPS52135337A (en) Process for manufacture of pigments having improved dispersibility and use thereof
PT65624A (en) Process of preparation of 4-hydroxymethyl-2-pyrrolidinone
JPS51149293A (en) Production of novel 22 substituted 1*44benzodiazepine and nerve center acting agent containing same
GR60799B (en) Preparation process of anthelminthically active 2-carbalkoxyamino-5(6)-phenyl-sulfonyloxy-benzimidazol
JPS51115496A (en) Production of novel 11 deoxyyriboflanulonic acid derivatines and medicine containing same